CymoGen Dx Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
CymoGen Dx General Information
Description
Provider of research products for clinical, research and biopharmaceutical customers. The company engages in the application of fluorescence-based DNA detection technology and provides tools for identifying genomic aberrations in cancer cells found in tissue and bone marrow specimens.
Contact Information
Corporate Office
- 4 Crotty Lane
- Suite 100
- New Windsor, NY 12553
- United States
Corporate Office
- 4 Crotty Lane
- Suite 100
- New Windsor, NY 12553
- United States
CymoGen Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 09-Mar-2015 | Completed | Generating Revenue | |||
| 1. Angel (individual) | 06-Jul-2010 | Completed | Startup |
CymoGen Dx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CymoGen Dx FAQs
-
When was CymoGen Dx founded?
CymoGen Dx was founded in 2010.
-
Where is CymoGen Dx headquartered?
CymoGen Dx is headquartered in New Windsor, NY.
-
What industry is CymoGen Dx in?
CymoGen Dx’s primary industry is Other Devices and Supplies.
-
Is CymoGen Dx a private or public company?
CymoGen Dx is a Private company.
-
What is CymoGen Dx’s current revenue?
The current revenue for CymoGen Dx is .
-
How much funding has CymoGen Dx raised over time?
CymoGen Dx has raised $350K.
-
When was CymoGen Dx acquired?
CymoGen Dx was acquired on 09-Mar-2015.
-
Who acquired CymoGen Dx?
CymoGen Dx was acquired by Biocare Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
